HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

(124)I-cMAb U36

chimeric monoclonal anti-human CD44 splice version 6 antibody for targeting and visualising human anaplastic thyroid carcinoma with PET
Also Known As:
124I-cMAb U36; cMAb U36
Networked: 17 relevant articles (0 outcomes, 9 trials/studies)

Bio-Agent Context: Research Results

Experts

1. van Dongen, Guus A M S: 7 articles (11/2009 - 11/2002)
2. Boellaard, Ronald: 6 articles (11/2009 - 08/2003)
3. Verel, Iris: 4 articles (12/2004 - 08/2003)
4. Visser, Gerard W M: 4 articles (12/2004 - 08/2003)
5. Snow, Gordon B: 4 articles (10/2003 - 11/2002)
6. Snow, G B: 4 articles (09/2001 - 10/2000)
7. van Dongen, G A: 4 articles (09/2001 - 10/2000)
8. Nestor, Marika: 3 articles (01/2010 - 09/2007)
9. Roos, Jan C: 3 articles (11/2009 - 11/2002)
10. de Bree, Remco: 3 articles (11/2009 - 11/2002)

Related Diseases

1. Squamous Cell Carcinoma of Head and Neck
2. Head and Neck Neoplasms (Head and Neck Cancer)
3. Neoplasms (Cancer)
4. Thyroid Neoplasms (Thyroid Cancer)
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Monoclonal Antibodies
2. (124)I-cMAb U36
3. Granulocyte Colony-Stimulating Factor (G-CSF)
4. Iodine
5. Immunoglobulin G (IgG)
6. 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
7. Immunoconjugates (Immunoconjugate)
8. Antigens
9. Acids
10. CD44v6 antigen

Related Therapies and Procedures

1. Radioimmunotherapy
2. Therapeutics
3. Neck Dissection (Radical Neck Dissection)